#Business #WallStreet
Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.
WSJ.com: US Business
PAID
This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.
